Literature DB >> 21840754

High prevalence of HTLV-I infection in Mashhad, Northeast Iran: a population-based seroepidemiology survey.

Houshang Rafatpanah1, Mohammad Reza Hedayati-Moghaddam, Farhad Fathimoghadam, Hamid Reza Bidkhori, Seyed Khosro Shamsian, Sanaz Ahmadi, Leila Sohgandi, Mahmoud Reza Azarpazhooh, Seyed Abdolrahim Rezaee, Reza Farid, Ali Bazarbachi.   

Abstract

BACKGROUND: Mashhad, in the northeast of Iran has been suggested as an endemic area for human T cell lymphotropic virus type I (HTLV-I) infection since 1996.
OBJECTIVES: We performed a community-based seroepidemiology study to examine the prevalence and risk factors for HTLV-I infection in the city of Mashhad. STUDY
DESIGN: Between May and September 2009, overall 1678 subjects from all the 12 geographical area of Mashhad were selected randomly by multistage cluster sampling for HTLV antibody. The study population included 763 males and 915 females, with the mean age of 29.1 ± 18.5 years. 1654 serum samples were assessed for HTLV antibody using ELISA and reactive samples were confirmed by Western blot and PCR.
RESULTS: The overall prevalence of HTLV-I infection in whole population was 2.12% (95% CI, 1.48-2.93) with no significant difference between males and females (p = 0.093) and the prevalence of HTLV-II seropositivity was 0.12% (95% CI, 0.02-0.44). The HTLV-I Infection was associated with age (p<0.001), marital status (p<0.001), education (p = 0.047), and history of blood transfusion (p = 0.009), surgery (p<0.001), traditional cupping (p = 0.002), and hospitalization (p = 0.004). In logistic regression analysis, age was the only variable that had a significant relation with the infection (p = 0.006, OR = 4.33).
CONCLUSIONS: Our results demonstrated that Mashhad still remains an endemic area for HTLV-I infection despite routine blood screening. Thus, further strategies are needed for prevention of the virus transmission in whole population.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21840754     DOI: 10.1016/j.jcv.2011.07.004

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  65 in total

1.  Triple Therapy with Prednisolone, Pegylated Interferon and Sodium Valproate Improves Clinical Outcome and Reduces Human T-Cell Leukemia Virus Type 1 (HTLV-1) Proviral Load, Tax and HBZ mRNA Expression in Patients with HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis.

Authors:  Reza Boostani; Rosita Vakili; Samane Sadat Hosseiny; Ali Shoeibi; Bahare Fazeli; Mohammad Mehdi Etemadi; Faeze Sabet; Narges Valizade; Seyed Abdolrahim Rezaee
Journal:  Neurotherapeutics       Date:  2015-10       Impact factor: 7.620

2.  Dietary Intake and Serum Selenium Levels Influence the Outcome of HTLV-1 Infection.

Authors:  Effat Saghi; Abdolreza Norouzy; Mohsen Nematy; Lida Jarahi; Reza Boostani; Fariba Zemorshidi; Zohreh Vahidi; Houshang Rafatpanah
Journal:  Biol Trace Elem Res       Date:  2020-11-09       Impact factor: 3.738

3.  JAK2 V617F Mutation in Adult T Cell Leukemia-Lymphoma.

Authors:  Hossein Ayatollahi; Mohammad Hadi Sadeghian; Mohammad Reza Keramati; Ehsan Ghayoor Karimiani; Amir Hossein Jafarian; Abbas Shirdel; Hossein Rahimi; Mohammad Esmaeel Zangane-Far; Arezoo Shajiei; Maryam Sheikhi
Journal:  Indian J Hematol Blood Transfus       Date:  2015-12-17       Impact factor: 0.900

4.  Altered Expression of Cell Cycle Regulators in Adult T-Cell Leukemia/ Lymphoma Patients.

Authors:  Reza Torshizi; Ehsan Ghayour Karimani; Kobra Etminani; Mohammad Mehdi Akbarin; Khadijeh Jamialahmadi; Abbas Shirdel; Hossein Rahimi; Abolghasem Allahyari; Amin Golabpour; Houshang Rafatpanah
Journal:  Rep Biochem Mol Biol       Date:  2017-10

5.  Assessment of HTLV-1 proviral load, LAT, BIM, c-FOS and RAD51 gene expression in adult T cell leukemia/lymphoma.

Authors:  Samaneh Ramezani; Abbas Shirdel; Houshang Rafatpanah; Mohammad Mehdi Akbarin; Hanieh Tarokhian; Hossein Rahimi; Alireza Bari; Hamid Reza Jahantigh; Seyed Abdolrahim Rezaee
Journal:  Med Microbiol Immunol       Date:  2017-05-02       Impact factor: 3.402

6.  Role of IL-21 in HTLV-1 infections with emphasis on HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).

Authors:  Taraneh Rajaei; Hamid Farajifard; Houshang Rafatpanah; Reza Bustani; Narges Valizadeh; Bahareh Rajaei; Seyed Abdolrahim Rezaee
Journal:  Med Microbiol Immunol       Date:  2017-04-04       Impact factor: 3.402

7.  HTLV-1-infected asymptomatic carriers compared to HAM/TSP patients over-express the apoptosis- and cytotoxicity-related molecules.

Authors:  Asadollah Mohammadi; Bahare Fazeli; Zohreh Poursina; Farahnaz Tehranian; Veda Vakili; Reza Boostani; Houshang Rafatpanah
Journal:  Med Microbiol Immunol       Date:  2019-07-18       Impact factor: 3.402

8.  Human T lymphotropic virus types 1 and 2: a point of view.

Authors:  Angela Cristina Malheiros Luzo
Journal:  Rev Bras Hematol Hemoter       Date:  2013

9.  Different roles of CXCR1 and CXCR2 in HTLV-1 carriers and HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients.

Authors:  Taraneh Rajaei; Hamid Farajifard; Seyed Abdolrahim Rezaee; Mahmoud Reza Azarpazhooh; Mahmoud Mahmoudi; Narges Valizadeh; Houshang Rafatpanah
Journal:  Med Microbiol Immunol       Date:  2018-10-20       Impact factor: 3.402

10.  Evaluation of iron, ferritin, copper, and ceruloplasmin along with proviral load in human T lymphotropic virus type 1-associated myelopathy.

Authors:  Reza Boostani; Mina Khodabandeh; Seyyed Abdolrahim Rezaee; Houshang Rafatpanah; Sanaz Ahmadi Ghezeldasht; Zohreh Vahidi; Zahra Baghestani
Journal:  J Neurovirol       Date:  2021-04-20       Impact factor: 2.643

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.